Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Zhang, L. et al. (2022) Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction. Circulation, 146(13), pp. 1411-1414. (doi: 10.1161/CIRCULATIONAHA.122.061481) (PMID:36029463)

Abstract

No abstract available.

• Item Type: Articles
• Additional Information: The PARADIGM-HF and ATMOSPHERE trials, and this proteomic study, were funded by Novartis.
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Jhund, Professor Pardeep and Kober, Professor Lars and McMurray, Professor John
• Authors: Zhang, L., Cunningham, J. W., Claggett, B. L., Jacob, J., Mendelson, M. M., Serrano-Fernandez, P., Kaiser, S., Yates, D. P., Healey, M., Chen, C.-W., Turner, G. M., Patel-Murray, N., Zhao, F., Beste, M. T., Laramie, J. M., Abraham, W. T., Jhund, P. S., Kober, L., Packer, M., Rouleau, J., Zile, M. R., Prescott, M. F., Lefkowitz, M., McMurray, J. J.V., Solomon, S. D., and Chutkow, W.
• College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
• Journal Name: Circulation
• Publisher: American Heart Association
• ISSN: 0009-7322
• ISSN (Online): 1524-4539
• Published Online: 27 August 2022
• Copyright Holders: Copyright © 2022 American Heart Association, Inc.
• First Published: First published in Circulation 146(18): 1411-1414
• Publisher Policy: Reproduced in accordance with the publisher copyright policy

Related URLs

• Author